Physiologic Changes During Helium Insufflation In High-Risk Patients During Laparoscopic Renal Procedures
Main Category: Prostate / Prostate CancerAlso Included In: Men's health; Urology / Nephrology; Clinical Trials / Drug Trials
Article Date: 21 Nov 2007 - 0:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
UroToday.com- In the August, 2007 issue of the Journal of Endourology Dr. Ashutosh Tewari, et al describe a new technique for preserving potency in men with high risk prostate cancer (CaP). The tested this technique in 7 men.
The study addressed the need for neurovascular bundle (NVB) resection in men at risk for extraprostatic tumor extension. The nerve advancement technique (NAT) was based upon the robotic prostatectomy platform. The NVB to be resected was mobilized and following resection of the specific area, an "end-to-end" or "end-to-side" anastomosis was performed using 6-0 polypropylene sutures.
The study population consisted of 7 men who had high-risk CaP features or MRI suggestion of extra-capsular extension or intraoperative features mandating the NVB section be resected. Sexual Health Inventory for Men (SHIM) scores was obtained preoperatively and at 1, 3, 6, 12, and 18 months after surgery. Oncology outcomes were also assessed.
Most of the 7 participants had stage pT3 disease and one patient had a positive surgical margin. At final follow-up, 5 men had an undetectable PSA and 2 received salvage radiotherapy for PSA relapse. The mean SHIM score was 22 before surgery and 18 after surgery. Five men (71.4%) were able to achieve sexual intercourse with or without a phosphodiesterase-5 inhibitor. While this study is small and non-randomized, it suggests that NAT may be developed into another option to retain potency in men requiring NVB resection. The researchers are evaluating the technique in an animal model to better define it.
Martinez-Salamanca JI, Rao S, Ramanathan R, Gonzalez J, Mandhani A, Yang X, Tu J, Vaughan ED, Tewari A
J Endourol. 21(8):830-835, August 2007
Doi: 10.1089/end.2007.9946
Reported by UroToday.com Contributing Editor Christopher P. Evans, M.D
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
----------------------------
Copyright © 2007 - UroToday
Reproduced for Medical News Today with permission of UroToday.
----------------------------
Visit our prostate / prostate cancer section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/89422.php>
APA
http://www.medicalnewstoday.com/releases/89422.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



